Division of Orthopaedic Surgery, McGill University Health Centre, 1650 Cedar Avenue, Room B5.159.6, Montreal, Quebec, Canada H3G 1A4.
Int Orthop. 2012 Sep;36(9):1807-12. doi: 10.1007/s00264-012-1570-1. Epub 2012 Jun 9.
Long-term studies are required to support the use of metal-on-metal (MoM) bearings in total hip arthroplasty (THA) given the concern about systemic metal ion release and reports of adverse local soft tissue reactions. The purpose of this study was to report the seven to 13-year clinical, radiographic, and metal ion results in patients following MoM THA.
We studied 163 prostheses after second-generation MoM THA between July 1997 and November 2003. Cobalt and chromium metal ions were collected using whole and analysed by inductively-coupled plasma-mass spectrometry.
The mean follow-up was 8.87 years (range, 7-13 years). Four hips (2.5 %) were revised. The Kaplan-Meier survivorship was 91.3 % for revision for all causes, and 97.5 % when excluding the hips revised for a manufacturer's defect. Median whole blood cobalt levels peaked at a value of 2.87 μg/L at four years (p < 0.0001 vs. pre-operative) and subsequently decreased to 2.0 μg/L after nine years (p = 0.002 vs. four years). Median chromium levels maximally increased up to 0.75 μg/L after five years (p < 0.0001 vs. pre-operative) and tended to decrease thereafter to values of 0.56 μg/L after seven years.
This seven to 13-year follow-up study indicates that the clinical and radiological results following MoM THA are satisfactory with low revision rates. Cobalt and chromium ion levels peaked at four and five years, respectively, and gradually decreased thereafter.
鉴于对全身性金属离子释放的担忧以及不良局部软组织反应的报道,需要进行长期研究来支持金属对金属(MoM)轴承在全髋关节置换术(THA)中的应用。本研究的目的是报告 MoM-THA 后 7 至 13 年的临床、影像学和金属离子结果。
我们研究了 1997 年 7 月至 2003 年 11 月期间接受第二代 MoM-THA 的 163 例假体。使用电感耦合等离子体质谱法收集钴和铬金属离子并进行分析。
平均随访时间为 8.87 年(7-13 年)。4 髋(2.5%)接受了翻修。所有原因的 Kaplan-Meier 生存率为 91.3%,排除因制造商缺陷而翻修的髋关节后为 97.5%。全血钴水平中位数在四年时达到 2.87μg/L 的峰值(p<0.0001 与术前相比),随后在九年时降至 2.0μg/L(p=0.002 与四年时相比)。铬水平中位数在五年时最高增加至 0.75μg/L(p<0.0001 与术前相比),此后趋于下降,七年时降至 0.56μg/L。
这项 7 至 13 年的随访研究表明,MoM-THA 后的临床和影像学结果令人满意,翻修率低。钴和铬离子水平分别在四年和五年时达到峰值,此后逐渐下降。